What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis.
Vale CL, Fisher DJ, White IR, Carpenter JR, Burdett S, Clarke NW, Fizazi K, Gravis G, James ND, Mason MD, Parmar MKB, Rydzewska LH, Sweeney CJ, Spears MR, Sydes MR, Tierney JF.
Vale CL, et al. Among authors: white ir.
Ann Oncol. 2018 May 1;29(5):1249-1257. doi: 10.1093/annonc/mdy071.
Ann Oncol. 2018.
PMID: 29788164
Free PMC article.